General Information of Drug Transporter (DT)
DT ID DTD0031 Transporter Info
Gene Name SLCO2B1
Transporter Name Organic anion transporting polypeptide 2B1
Gene ID
11309
UniProt ID
O94956
Exogenous Factors (drugs, dietary constituents, etc.) Modulating DT Activity (EFMDA)
Exogenous Factor Quercetin Approved Drug
DT Modulation Quercetin inhibits the transportation of Atorvastatin by SLCO2B1 (IC50 = 14.1 microM; Ki = 20.8 microM) [1]
Affected Drug/Substrate Atorvastatin Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
DT Modulation Quercetin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 9.47 microM) [4]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
DT Modulation Quercetin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Bromsulphthalein Investigative Drug
DT Modulation Bromsulphthalein inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 2 microM; Ki = 1.5 microM) [2]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human enterocyte-like 2 cell (Caco-2)-OATP2B1
DT Modulation Bromsulphthalein inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 1.7 microM) [3]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Monkey kidney tissue Fibroblast-like cell lines (COS1)-OATP2B1
DT Modulation Bromsulphthalein inhibits the transportation of Estrone sulfate by SLCO2B1 [6]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
DT Modulation Bromsulphthalein modulates the activity of SLCO2B1 [7]
Exogenous Factor Cyclosporine Approved Drug
DT Modulation Cyclosporine inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 20 microM) [8]
Affected Drug/Substrate Bromsulphthalein Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
DT Modulation Cyclosporine inhibits the transportation of Rosuvastatin by SLCO2B1 (IC50 = 0.07 microM) [10]
Affected Drug/Substrate Rosuvastatin Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
DT Modulation Cyclosporine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Rifampicin Approved Drug
DT Modulation Rifampicin inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 90 microM) [8]
Affected Drug/Substrate Bromsulphthalein Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
DT Modulation Rifampicin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 2.1 microM; Ki = 1.6 microM) [2]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human enterocyte-like 2 cell (Caco-2)-OATP2B1
DT Modulation Rifampicin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Rifamycin SV Approved Drug
DT Modulation Rifamycin SV inhibits the transportation of Bromsulphthalein by SLCO2B1 (Ki = 3 microM) [9]
Affected Drug/Substrate Bromsulphthalein Modulation Type Inhibition
Cell System Oocytes-OATP2B1
DT Modulation Rifamycin SV inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 3 microM; Ki = 2.3 microM) [2]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human enterocyte-like 2 cell (Caco-2)-OATP2B1
DT Modulation Rifamycin SV inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Hesperetin Approved Drug
DT Modulation Hesperetin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 67.6 microM) [4]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
DT Modulation Hesperetin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 1.92 microM) [4]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
DT Modulation Hesperetin inhibits the transportation of Estrone sulfate by SLCO2B1 [11]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
Exogenous Factor Naringin Investigative Drug
DT Modulation Naringin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 4.63 microM) [4]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
DT Modulation Naringin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
DT Modulation Naringin inhibits the transportation of Estrone sulfate by SLCO2B1 [11]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
Exogenous Factor Apple juice Dietary Constituent
DT Modulation Apple juice inhibits the transportation of Atenolol by SLCO2B1 [12]
Affected Drug/Substrate Atenolol Modulation Type Inhibition
Cell System Healthy people
DT Modulation Apple juice inhibits the transportation of Estrone sulfate by SLCO2B1 [11]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
DT Modulation Apple juice inhibits the activity of SLCO2B1 [13]
Cell System Patient samples
Exogenous Factor Orange juice Dietary Constituent
DT Modulation Orange juice inhibits the transportation of Aliskiren by SLCO2B1 (IC50 = 2.7 microM) [14]
Affected Drug/Substrate Aliskiren Modulation Type Inhibition
Cell System Healthy people
DT Modulation Orange juice inhibits the transportation of Estrone sulfate by SLCO2B1 [11]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
Exogenous Factor Kaempferol Investigative Drug
DT Modulation Kaempferol inhibits the transportation of Atorvastatin by SLCO2B1 (IC50 = 20.7 microM; Ki = 15.1 microM) [1]
Affected Drug/Substrate Atorvastatin Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
DT Modulation Kaempferol inhibits the transportation of Estrone sulfate by SLCO2B1 [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor MK-571 Discontinued Drug
DT Modulation MK-571 inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 0.2 microM) [8]
Affected Drug/Substrate Bromsulphthalein Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
DT Modulation MK-571 inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Paclitaxel Approved Drug
DT Modulation Paclitaxel inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 25 microM) [8]
Affected Drug/Substrate Bromsulphthalein Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
DT Modulation Paclitaxel inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Repaglinide Approved Drug
DT Modulation Repaglinide inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 5.2 microM) [15]
Affected Drug/Substrate Bromsulphthalein Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
DT Modulation Repaglinide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Atorvastatin Approved Drug
DT Modulation Atorvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 0.4 microM) [16]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
DT Modulation Atorvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Cerivastatin Approved Drug
DT Modulation Cerivastatin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 66.2 microM) [16]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
DT Modulation Cerivastatin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Indinavir Approved Drug
DT Modulation Indinavir inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 3.9 microM; Ki = 3 microM) [2]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human enterocyte-like 2 cell (Caco-2)-OATP2B1
DT Modulation Indinavir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Naringenin Drug in Phase 1 Trial
DT Modulation Naringenin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 49.2 microM) [4]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
DT Modulation Naringenin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ritonavir Approved Drug
DT Modulation Ritonavir inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 6.3 microM; Ki = 4.8 microM) [2]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human enterocyte-like 2 cell (Caco-2)-OATP2B1
DT Modulation Ritonavir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Saquinavir Approved Drug
DT Modulation Saquinavir inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 5.3 microM; Ki = 4 microM) [2]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human enterocyte-like 2 cell (Caco-2)-OATP2B1
DT Modulation Saquinavir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Simvastatin Approved Drug
DT Modulation Simvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 84.7 microM) [16]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
DT Modulation Simvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Gemfibrozil Approved Drug
DT Modulation Gemfibrozil inhibits the transportation of Rosuvastatin by SLCO2B1 (IC50 = 8 microM) [10]
Affected Drug/Substrate Rosuvastatin Modulation Type Inhibition
Cell System Human cervical cancer cell line (Hela)-OATP2B1
DT Modulation Gemfibrozil inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Testosterone Approved Drug
DT Modulation Testosterone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
DT Modulation Testosterone inhibits the activity of SLCO2B1 [18]
Exogenous Factor Apigenin Investigative Drug
DT Modulation Apigenin inhibits the transportation of Atorvastatin by SLCO2B1 (IC50 = 13.9 microM; Ki = 8.7 microM) [1]
Affected Drug/Substrate Atorvastatin Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Cigarette smoke condensate Natural Product
DT Modulation Cigarette smoke condensate inhibits the transportation of Bromosulfophtalein by by repressing mRNA expression of SLCO2B1 (IC50 = 39.5 microM) [19]
Affected Drug/Substrate Bromosulfophtalein Modulation Type Inhibition
Cell System Human hepatoma HepaRG cells-OATP2B1
Exogenous Factor Silibinin dihemisuccinate Natural Product
DT Modulation Silibinin dihemisuccinate inhibits the transportation of Bromosulfophthalein by SLCO2B1 (IC50 = 1 microM) [8]
Affected Drug/Substrate Bromosulfophthalein Modulation Type Inhibition
Cell System Madin darby canine kidney strain II cell line (MDCKII)-OATP2B1
Exogenous Factor Montelukast Approved Drug
DT Modulation Montelukast inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 1 microM) [8]
Affected Drug/Substrate Bromsulphthalein Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
Exogenous Factor Phloretin Investigative Drug
DT Modulation Phloretin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 1.31 microM) [4]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
Exogenous Factor Phloridzin Natural Product
DT Modulation Phloridzin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 23.2 microM) [4]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
Exogenous Factor Estrone Approved Drug
DT Modulation Estrone inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 2.5 microM; Ki = 1.9 microM) [2]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human enterocyte-like 2 cell (Caco-2)-OATP2B1
Exogenous Factor Ginkgo biloba Natural Product
DT Modulation Ginkgo biloba inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 11.2 +/- 3.3 microM) [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Silybin B Natural Product
DT Modulation Silybin B inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 0.8 microM) [20]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Silychristin Natural Product
DT Modulation Silychristin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 3.6 microM) [20]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Silybin A Natural Product
DT Modulation Silybin A inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 4.5 microM) [20]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ginkgo leaf extract Natural Product
DT Modulation Ginkgo leaf extract inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 11.2 microM) [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Green tea extract Natural Product
DT Modulation Green tea extract inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 22.1 microM) [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor (-)-epicatechin-3-gallate Natural Product
DT Modulation (-)-epicatechin-3-gallate inhibits the activity of SLCO2B1 in a substrate-dependent manner (IC50 = 36 microM) [21]
Cell System Chinese hamster ovary (CHO) cells-OATP2B1
Exogenous Factor (-)-epigallocatechin-3-gallate Natural Product
DT Modulation (-)-epigallocatechin-3-gallate inhibits the activity of SLCO2B1 in a substrate-dependent manner (IC50 = 101 microM) [21]
Cell System Chinese hamster ovary (CHO) cells-OATP2B1
Exogenous Factor Mesalazine Approved Drug
DT Modulation Mesalazine inhibits the transportation of Bromsulphthalein by SLCO2B1 [22]
Affected Drug/Substrate Bromsulphthalein Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Grapefruit juice Dietary Constituent
DT Modulation Grapefruit juice inhibits the transportation of Estrone sulfate by SLCO2B1 [11]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Xenopus laevis oocytes-OATP2B1
Exogenous Factor Acarbose Approved Drug
DT Modulation Acarbose inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Acyclovir Approved Drug
DT Modulation Acyclovir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Allopurinol Approved Drug
DT Modulation Allopurinol inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Amantadine Approved Drug
DT Modulation Amantadine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Amitriptyline Approved Drug
DT Modulation Amitriptyline inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Amodiaquine Approved Drug
DT Modulation Amodiaquine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Amprenavir Approved Drug
DT Modulation Amprenavir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Atazanavir Approved Drug
DT Modulation Atazanavir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Atenolol Approved Drug
DT Modulation Atenolol inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Atomoxetine Approved Drug
DT Modulation Atomoxetine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Benzbromarone Approved Drug
DT Modulation Benzbromarone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Benzoic acid Approved Drug
DT Modulation Benzoic acid inhibits the transportation of Estrone sulfate by SLCO2B1 [23]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Bestatin Approved Drug
DT Modulation Bestatin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Budesonide Approved Drug
DT Modulation Budesonide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Bupropion Approved Drug
DT Modulation Bupropion inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Buspirone Approved Drug
DT Modulation Buspirone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Caffeine Approved Drug
DT Modulation Caffeine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Candesartan Approved Drug
DT Modulation Candesartan inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Captopril Approved Drug
DT Modulation Captopril inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Carbamazepine Approved Drug
DT Modulation Carbamazepine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Cefadroxil Approved Drug
DT Modulation Cefadroxil inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Cefamandole Approved Drug
DT Modulation Cefamandole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Celecoxib Approved Drug
DT Modulation Celecoxib inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Cetirizine Approved Drug
DT Modulation Cetirizine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Chloroquine Approved Drug
DT Modulation Chloroquine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Chlorpromazine Approved Drug
DT Modulation Chlorpromazine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Chlorprothixene Approved Drug
DT Modulation Chlorprothixene inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Chlorzoxazone Approved Drug
DT Modulation Chlorzoxazone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Cholic acid Approved Drug
DT Modulation Cholic acid inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Cimetidine Approved Drug
DT Modulation Cimetidine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Clarithromycin Approved Drug
DT Modulation Clarithromycin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Clotrimazole Approved Drug
DT Modulation Clotrimazole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Colchicine Approved Drug
DT Modulation Colchicine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Desipramine Approved Drug
DT Modulation Desipramine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Dexamethasone Approved Drug
DT Modulation Dexamethasone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Dextromethorphan Approved Drug
DT Modulation Dextromethorphan inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Diazepam Approved Drug
DT Modulation Diazepam inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Diclofenac Approved Drug
DT Modulation Diclofenac inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Diethylstilbestrol Approved Drug
DT Modulation Diethylstilbestrol inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Digoxin Approved Drug
DT Modulation Digoxin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Diltiazem Approved Drug
DT Modulation Diltiazem inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Dipyridamole Approved Drug
DT Modulation Dipyridamole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Disopyramide Approved Drug
DT Modulation Disopyramide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Disulfiram Approved Drug
DT Modulation Disulfiram inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Dofetilide Approved Drug
DT Modulation Dofetilide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Doxazosin Approved Drug
DT Modulation Doxazosin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Doxorubicin Approved Drug
DT Modulation Doxorubicin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Efavirenz Approved Drug
DT Modulation Efavirenz inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Eletriptan Approved Drug
DT Modulation Eletriptan inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Emtricitabine Approved Drug
DT Modulation Emtricitabine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Enalapril Approved Drug
DT Modulation Enalapril inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Erlotinib Approved Drug
DT Modulation Erlotinib inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Erythromycin Approved Drug
DT Modulation Erythromycin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Estradiol Approved Drug
DT Modulation Estradiol inhibits the transportation of Estrone sulfate by SLCO2B1 [5], [24]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Etoposide Approved Drug
DT Modulation Etoposide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ezetimibe Approved Drug
DT Modulation Ezetimibe inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Felodipine Approved Drug
DT Modulation Felodipine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Fenofibrate Approved Drug
DT Modulation Fenofibrate inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Fentanyl Approved Drug
DT Modulation Fentanyl inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Fexofenadine Approved Drug
DT Modulation Fexofenadine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Fluconazole Approved Drug
DT Modulation Fluconazole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Fluoxetine Approved Drug
DT Modulation Fluoxetine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Flutamide Approved Drug
DT Modulation Flutamide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Fluvastatin Approved Drug
DT Modulation Fluvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Fluvoxamine Approved Drug
DT Modulation Fluvoxamine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Furosemide Approved Drug
DT Modulation Furosemide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Glibenclamide Approved Drug
DT Modulation Glibenclamide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Glipizide Approved Drug
DT Modulation Glipizide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ibuprofen Approved Drug
DT Modulation Ibuprofen inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Imipramine Approved Drug
DT Modulation Imipramine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Indocyanine green Approved Drug
DT Modulation Indocyanine green inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Indomethacin Approved Drug
DT Modulation Indomethacin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Irinotecan Approved Drug
DT Modulation Irinotecan inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Isoniazid Approved Drug
DT Modulation Isoniazid inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Isradipine Approved Drug
DT Modulation Isradipine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ivermectin Approved Drug
DT Modulation Ivermectin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ketoconazole Approved Drug
DT Modulation Ketoconazole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Lamotrigine Approved Drug
DT Modulation Lamotrigine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Lansoprazole Approved Drug
DT Modulation Lansoprazole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor L-carnitine Approved Drug
DT Modulation L-carnitine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Levofloxacin Approved Drug
DT Modulation Levofloxacin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Levothyroxine Approved Drug
DT Modulation Levothyroxine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Lisinopril Approved Drug
DT Modulation Lisinopril inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Loperamide Approved Drug
DT Modulation Loperamide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Lopinavir Approved Drug
DT Modulation Lopinavir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Loratadine Approved Drug
DT Modulation Loratadine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Lovastatin Approved Drug
DT Modulation Lovastatin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Mephenytoin Approved Drug
DT Modulation Mephenytoin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Metformin Approved Drug
DT Modulation Metformin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Methotrexate Approved Drug
DT Modulation Methotrexate inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Methoxsalen Approved Drug
DT Modulation Methoxsalen inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Metoprolol Approved Drug
DT Modulation Metoprolol inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Midazolam Approved Drug
DT Modulation Midazolam inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Mifepristone Approved Drug
DT Modulation Mifepristone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Mitoxantrone Approved Drug
DT Modulation Mitoxantrone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Moclobemide Approved Drug
DT Modulation Moclobemide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Nefazodone Approved Drug
DT Modulation Nefazodone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Nelfinavir Approved Drug
DT Modulation Nelfinavir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Nicardipine Approved Drug
DT Modulation Nicardipine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Nicotine Approved Drug
DT Modulation Nicotine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Nifedipine Approved Drug
DT Modulation Nifedipine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Nitrofurantoin Approved Drug
DT Modulation Nitrofurantoin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Novobiocin Approved Drug
DT Modulation Novobiocin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Nystatin Approved Drug
DT Modulation Nystatin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Olmesartan medoxomil Approved Drug
DT Modulation Olmesartan medoxomil inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Omeprazole Approved Drug
DT Modulation Omeprazole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ondansetron Approved Drug
DT Modulation Ondansetron inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ouabain Approved Drug
DT Modulation Ouabain inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Pantoprazole Approved Drug
DT Modulation Pantoprazole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Paroxetine Approved Drug
DT Modulation Paroxetine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Phenobarbital Approved Drug
DT Modulation Phenobarbital inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Phenylbutazone Approved Drug
DT Modulation Phenylbutazone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Phenytoin Approved Drug
DT Modulation Phenytoin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Pilsicainide Approved Drug
DT Modulation Pilsicainide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Pindolol Approved Drug
DT Modulation Pindolol inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Pioglitazone Approved Drug
DT Modulation Pioglitazone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Piroxicam Approved Drug
DT Modulation Piroxicam inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Pravastatin Approved Drug
DT Modulation Pravastatin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Prazosin Approved Drug
DT Modulation Prazosin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Prednisolone Approved Drug
DT Modulation Prednisolone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Probenecid Approved Drug
DT Modulation Probenecid inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Procainamide Approved Drug
DT Modulation Procainamide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Progesterone Approved Drug
DT Modulation Progesterone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Propranolol Approved Drug
DT Modulation Propranolol inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Quinine Approved Drug
DT Modulation Quinine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ranolazine Approved Drug
DT Modulation Ranolazine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Reserpine Approved Drug
DT Modulation Reserpine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Rosuvastatin Approved Drug
DT Modulation Rosuvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Sanguinarine Approved Drug
DT Modulation Sanguinarine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Sildenafil Approved Drug
DT Modulation Sildenafil inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Sotalol Approved Drug
DT Modulation Sotalol inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Spironolactone Approved Drug
DT Modulation Spironolactone inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Sulfaphenazole Approved Drug
DT Modulation Sulfaphenazole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Sulfasalazine Approved Drug
DT Modulation Sulfasalazine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Tamoxifen Approved Drug
DT Modulation Tamoxifen inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Telmisartan Approved Drug
DT Modulation Telmisartan inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Tenofovir Approved Drug
DT Modulation Tenofovir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Tetracycline Approved Drug
DT Modulation Tetracycline inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Theophylline Approved Drug
DT Modulation Theophylline inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Thioridazine Approved Drug
DT Modulation Thioridazine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Thiotepa Approved Drug
DT Modulation Thiotepa inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Ticlopidine Approved Drug
DT Modulation Ticlopidine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Tipranavir Approved Drug
DT Modulation Tipranavir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Tolbutamide Approved Drug
DT Modulation Tolbutamide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Topotecan Approved Drug
DT Modulation Topotecan inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Triazolam Approved Drug
DT Modulation Triazolam inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Trimethoprim Approved Drug
DT Modulation Trimethoprim inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Valacyclovir Approved Drug
DT Modulation Valacyclovir inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Valproic Acid Approved Drug
DT Modulation Valproic Acid inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Valsartan Approved Drug
DT Modulation Valsartan inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Varenicline Approved Drug
DT Modulation Varenicline inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Verapamil Approved Drug
DT Modulation Verapamil inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Vinblastine Approved Drug
DT Modulation Vinblastine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Vincristine Approved Drug
DT Modulation Vincristine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Warfarin Approved Drug
DT Modulation Warfarin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Zidovudine Approved Drug
DT Modulation Zidovudine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor PRX-321 Drug in Phase 2 Trial
DT Modulation PRX-321 inhibits the transportation of Estrone sulfate by SLCO2B1 [20]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
Exogenous Factor Silibinin Drug in Phase 2/3 Trial
DT Modulation Silibinin inhibits the transportation of Estrone sulfate by SLCO2B1 [20]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1
Exogenous Factor Astemizole Drug Withdrawn
DT Modulation Astemizole inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Baicalin Discontinued Drug
DT Modulation Baicalin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Benzylpenicillin Drug in Phase 3 Trial
DT Modulation Benzylpenicillin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Berberine Drug in Phase 4 Trial
DT Modulation Berberine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Elacridar Discontinued Drug
DT Modulation Elacridar inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Fendiline Drug Withdrawn
DT Modulation Fendiline inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Genistein Drug in Phase 2 Trial
DT Modulation Genistein inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Glycyrrhizin Drug in Phase 3 Trial
DT Modulation Glycyrrhizin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Phenacetin Drug Withdrawn
DT Modulation Phenacetin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Phenformin Drug Withdrawn
DT Modulation Phenformin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Sodium taurocholate Drug in Phase 1/2 Trial
DT Modulation Sodium taurocholate inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Terfenadine Drug Withdrawn
DT Modulation Terfenadine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Valspodar Discontinued Drug
DT Modulation Valspodar inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Silymarin flavolignans Natural Product
DT Modulation Silymarin flavolignans inhibits the transportation of Estrone sulfate by SLCO2B1 [20]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Madin darby canine kidney strain II cell line (MDCKII)-OATP2B1
Exogenous Factor Aminohippuric acid Investigative Drug
DT Modulation Aminohippuric acid inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Bilberry extract Natural Product
DT Modulation Bilberry extract inhibits the transportation of Estrone sulfate by SLCO2B1 [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Black cohosh extract Natural Product
DT Modulation Black cohosh extract inhibits the transportation of Estrone sulfate by SLCO2B1 [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Chelerythrine Investigative Drug
DT Modulation Chelerythrine inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Coumarin Investigative Drug
DT Modulation Coumarin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Coumestrol Investigative Drug
DT Modulation Coumestrol inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Daidzein Investigative Drug
DT Modulation Daidzein inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Echinacea extract Natural Product
DT Modulation Echinacea extract inhibits the transportation of Estrone sulfate by SLCO2B1 [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Glycochenodeoxycholic acid Investigative Drug
DT Modulation Glycochenodeoxycholic acid inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Glycocholic acid Investigative Drug
DT Modulation Glycocholic acid inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Glycodeoxycholic acid Investigative Drug
DT Modulation Glycodeoxycholic acid inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Herbal extract Natural Product
DT Modulation Herbal extracts inhibits the transportation of Estrone sulfate by SLCO2B1 [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Isorhamnetin Natural Product
DT Modulation Isorhamnetin inhibits the transportation of Estrone sulfate by SLCO2B1 [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Morin Investigative Drug
DT Modulation Morin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Phalloidin Investigative Drug
DT Modulation Phalloidin inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Sincalide Investigative Drug
DT Modulation Sincalide inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Soybean extract Natural Product
DT Modulation Soybean extract inhibits the transportation of Estrone sulfate by SLCO2B1 [17]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Taurochenodeoxycholate Investigative Drug
DT Modulation Taurochenodeoxycholate inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Tetraethylammonium Investigative Drug
DT Modulation Tetraethylammonium inhibits the transportation of Estrone sulfate by SLCO2B1 [5]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-OATP2B1
Exogenous Factor Allethrin Natural Product
DT Modulation Allethrin induces the transportation of Fluorescein by SLCO2B1 [25]
Affected Drug/Substrate Fluorescein Modulation Type Inducer
Cell System Chinese hamster ovary (CHO) cells-OATP2B1
Exogenous Factor Tetramethrin Natural Product
DT Modulation Tetramethrin induces the transportation of Fluorescein by SLCO2B1 [25]
Affected Drug/Substrate Fluorescein Modulation Type Inducer
Cell System Chinese hamster ovary (CHO) cells-OATP2B1
Exogenous Factor Eltrombopag Approved Drug
DT Modulation Eltrombopag inhibits the transportation of Estrone sulfate by SLCO2B1 [6]
Affected Drug/Substrate Estrone sulfate Modulation Type Inhibition
Exogenous Factor Citrus juice Dietary Constituent
DT Modulation Citrus juice inhibits the transportation of Montelukast by SLCO2B1 [26]
Affected Drug/Substrate Montelukast Modulation Type Inhibition
Exogenous Factor Mix silybin A silybin B Natural Product
DT Modulation Mix silybin A silybin B inhibits the activity of SLCO2B1 [27]
Cell System Chinese hamster ovary (CHO) cells-OATP2B1
Exogenous Factor Ergoloid mesylates Approved Drug
DT Modulation Ergoloid mesylates inhibits the activity of SLCO2B1 [28]
Exogenous Factor Estrone sulfate Investigative Drug
DT Modulation Estrone sulfate modulates the activity of SLCO2B1 [7]
References
1 Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem Pharmacol. 2010 Dec 1;80(11):1746-53.
2 Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1. Xenobiotica. 2010 Mar;40(3):163-76.
3 Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides. Drug Metab Dispos. 2009 Dec;37(12):2375-82.
4 Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions. J Pharm Sci. 2013 Jan;102(1):280-8.
5 Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. J Med Chem. 2012 May 24;55(10):4740-63.
6 Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent. Drug Metab Dispos. 2011 Jun;39(6):1088-96.
7 The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1224). Nucleic Acids Res. 2015 Oct 12. pii: gkv1037.
8 Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci. 2006 May;91(1):140-9.
9 Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology. 2002 Jul;36(1):164-72.
10 Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology. 2006 May;130(6):1793-806.
11 Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions. J Pharm Sci. 2013 Sep;102(9):3418-26.
12 Apple juice greatly reduces systemic exposure to atenolol. Br J Clin Pharmacol. 2013 Jan;75(1):172-9.
13 The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. Pharmacogenet Genomics. 2011 Feb;21(2):84-93.
14 Effects of orange juice on the pharmacokinetics of atenolol. Eur J Clin Pharmacol. 2005 Jul;61(5-6):337-40.
15 Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1. Diabetes. 2008 Jun;57(6):1463-9.
16 Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clin Pharmacol Ther. 2006 Dec;80(6):607-20.
17 Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos. 2006 Apr;34(4):577-82.
18 Modification of OATP2B1-mediated transport by steroid hormones. Mol Pharmacol. 2006 Nov;70(5):1735-41.
19 Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. Toxicology. 2016 Jul 1;363-364:58-71.
20 Interaction of silymarin flavonolignans with organic anion-transporting polypeptides. Drug Metab Dispos. 2013 May;41(5):958-65.
21 Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos. 2011 May;39(5):920-6.
22 Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. Drug Metab Dispos. 2011 Jun;39(6):1097-102.
23 Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther. 2003 Aug;306(2):703-8.
24 Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. Pharm Res. 2001 Sep;18(9):1262-9.
25 Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin. PLoS One. 2017 Jan 18;12(1):e0169480.
26 Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast. J Clin Pharmacol. 2011 May;51(5):751-60.
27 Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin. Drug Metab Dispos. 2013 Aug;41(8):1522-8.
28 The effects of ergoloid mesylates and ginkgo biloba on the pharmacokinetics of ticlopidine. J Clin Pharmacol. 2006 Jun;46(6):628-34.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.